Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 30,000 shares at $18.76 ($593K) on 2017-06-26, disclosed to the SEC on 2017-06-28.
Open-market sale of $593k BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.76 | 5,000 | $94K | 15.8% |
| 2 | $18.76 | 5,000 | $94K | 15.8% |
| 3 | $19.52 | 2,824 | $55K | 9.3% |
| 4 | $19.52 | 2,824 | $55K | 9.3% |
| 5 | $20.59 | 7,176 | $148K | 24.9% |
| 6 | $20.59 | 7,176 |
| $148K |
| 24.9% |
| Total | $19.78 avg | 30,000 | $593K | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |